Skip to main content
. 2020 Oct 31;6(6):364–372. doi: 10.1007/s40495-020-00243-4

Table 3.

Data from patients that evolved with death

Patient Gender Age Underlying disease Drug Dur treat (M) DD (mg/d) RD Cause of death
25 F 59 RA CQ 10 250 No Cardiac insufficiency and broncopneumonia
29 M 68 RA CQ 31 250 No Myocardial infarction
31 M 77 Psoriatic arthritis HQC 74 400 No Sepsis
32 F 78 RA CQ 28 250 No Heart failure
44 F 88 RA HQC 60 600 Y Obstructive airway disease
45 F 56 SLE/SS/autoimmune hepatitis HQC 6 400 Y Gallstones and sepsis
46 F 64 PSS/ILD HQC 48 400 Y Pulmonary fibrosis/Nocardia/Aspergillus

CQ, chloroquine; HQC, hydroxichloroquine; Dur treat (M), duration of treatment; DD, daily dose; RD, respiratory distress; M, months; m/d, milligrams per day; Y, yes